Clinical Trials Directory

Trials / Completed

CompletedNCT02558283

A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
175 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a safety and efficacy study of JUVÉDERM® VOLIFT® with Lidocaine and Restylane® in Chinese adults with nasolabial folds.

Conditions

Interventions

TypeNameDescription
DEVICEJUVÉDERM® VOLIFT® with LidocaineJUVÉDERM® VOLIFT® with lidocaine injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.
DEVICERestylane®Restylane® injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.

Timeline

Start date
2016-01-25
Primary completion
2017-06-19
Completion
2017-06-19
First posted
2015-09-23
Last updated
2017-08-30

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02558283. Inclusion in this directory is not an endorsement.